Sep 30, 2021 8:45am EDT DiaMedica Therapeutics Announces Fast Track Designation Granted to DM199 for the Treatment of Acute Ischemic Stroke
Sep 13, 2021 8:32am EDT DiaMedica Therapeutics Initiates Pivotal Trial of DM199 for the Treatment of Acute Ischemic Stroke
Aug 11, 2021 4:30pm EDT DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2021 Financial Results
Aug 05, 2021 8:12am EDT DiaMedica Therapeutics to Report Second Quarter 2021 Financial Results and Provide a Business Update August 12, 2021
Jul 28, 2021 4:28pm EDT DiaMedica Therapeutics to Participate in the BTIG Virtual Biotechnology Conference
Jul 15, 2021 4:15pm EDT DiaMedica Therapeutics Elects Two Industry Veterans to Its Board of Directors
Jun 29, 2021 6:58am EDT DiaMedica Therapeutics Announces Positive Interim Results from Phase 2 REDUX Study in CKD
